• DOI:10.1016/S0140-6736(98)07422-4
Corpus ID: 19355109

BCG immunotherapy of bladder cancer: 20 years on

@article{Alexandroff1999BCGIO,
  title={BCG immunotherapy of bladder cancer: 20 years on},
  author={A. Alexandroff and A. Jackson and M. O'Donnell and K. James},
  journal={The Lancet},
  year={1999},
  volume={353},
  pages={1689-1694}
}

A. Alexandroff, A. Jackson, +1 author K. James

Published 1999

Medicine

The Lancet

1The situation is similar for most industrialised western nations, with incidence rates of 18 to 30 new cases per 10 0 000 men placing bladder cancer among the top five cancers in this sex. It is unclear why women are affected a third to a quarter less often than men. In 75% of patients the disease is diagnosed in its early superficial stage, usually as a result of gross or microscopic blood in the urine. However, with an overall 65% recurrence rate and 30% progression rate, even these patients… CONTINUE READING

View on Elsevier

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed